Table 1.
In vivo Pharmacological Effects of α7-nAChR Ligands
Compound Name | α7 nAChR activity & other actions | Cognitive Domain Enhanced | Additional Behavioral Improvements | References |
---|---|---|---|---|
ABBF | α7 full agonist & 5-HT3 antagonist | object and social recognition, working memory | Boess et al., 2007 | |
ABT-107 | α7 full agonist | attention, working memory, social recognition | auditory gating | Bitner et al., 2010; Bordia et al., 2015; Radek et al., 2012 |
A-582941 | α7 full agonist | working memory, social recognition, inhibitory avoidance | sensory gating | Tietje et al., 2008 |
AQW051 | α7 partial agonist | object and social recognition, spatial reference memory | Feuerbach et al., 2015 | |
AVL-3288 (Compound 6, CCMI or XY4083) | α7 Type I PAM | object recognition, social recognition, working memory, executive function | auditory gating, conditioned avoidance responding | Ng et al., 2007; Nikiforuk et al., 2015 |
BMS-933043 | α7 partial agonist | object recognition, working memory, executive function | auditory gating | Bristow et al., 2016 |
BMS-902483 | α7 partial agonist & 5-HT3 antagonist | object recognition, executive function | auditory gating | Pieschl et al., 2017 |
Compound 7z | α7 Type I PAM | object recognition | Hogenkamp et al., 2013 | |
DMXB-A (GTS-21) | α7 partial agonist & 5-HT3 antagonist | attention, object recognition, spatial reference memory, working memory | sensorimotor gating | Meyer et al, 1997; Callahan et al., 2014; Jones et al., 2014 |
EVP-6124 (encenicline) | α7 partial agonist & 5-HT3 antagonist | object recognition | Prickaerts et al., 2012 | |
EVP-5141 | α7 full agonist & 5-HT3 antagonist | object and social recognition, working memory | Boess et al., 2013 | |
JNJ-39393406 | α7 Type I, Type II PAM | object recognition, executive function | auditory gating | Winterer et al., 2013 |
Lu AF58801 | α7 Type I PAM | object recognition | Eskildsen et al., 2014 | |
NS1738 | α7 Type I PAM | object and social recognition, spatial reference memory | Marcus et al., 2016; Timmermann et al., 2007 | |
PAM-2 | α7 Type II PAM | object recognition, executive function | social interaction model | Potasiewicz et al., 2017 |
PNU 120596 | α7 Type II PAM | recognition memory, spatial learning, working memory, executive function | auditory gating | Dunlop et al., 2009; Nikiforuk et al., 2015; Stevens et al., 2015 |
PNU-282987 | α7 full agonist | recognition memory | conditioned avoidance responding | McLean et al., 2016; Marcus et al., 2016 |
RG 3487 | α7 partial agonist & 5-HT3 antagonist | attention, object recognition, spatial reference memory, executive function | sensorimotor gating | Wallace et al., 2011 |
SEN-12333 | α7 full agonist & histamine H3 antagonist | object recognition | sensorimotor gating | Roncarati et al., 2009 |
SSR-180711 | α7 partial agonist | recognition memory, working memory, novelty discrimination | latent inhibition | Pichat et al., 2007; Barak et al., 2009 |
TC-5619 | α7 full agonist | object recognition | sensorimotor gating | Hauser et al., 2009 |
Tropisetron | α7 partial agonist & 5-HT3 antagonist | attention, object recognition, working memory, spatial reference memory | sensorimotor gating | Callahan et al., 2017; Hashimoto et al., 2005, 2006; Kohnomi et al., 2010; Pitsikas et al., 1997 |